Related Experiment Video
Updated: Dec 1, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Predicting Alzheimer's conversion in mild cognitive impairment patients using longitudinal neuroimaging and clinical
Carlos Platero1, M Carmen Tobar2,
1Health Science Technology Group, Universidad Politécnica de Madrid, Ronda de Valencia 3, 28012, Madrid, Spain. carlos.platero@upm.es.
Abstract:
Patients with mild cognitive impairment (MCI) have a high risk for conversion to Alzheimer's disease (AD). Early diagnose of AD in MCI subjects could help to slow or halt the disease progression. Selecting a set of relevant markers from multimodal data to predict conversion from MCI to probable AD has become a challenging task. The aim of this paper is to quantify the impact of longitudinal predictive models with single- or multisource data for predicting MCI-to-AD conversion and identifying a very small subset of features that are highly predictive of conversion. We developed predictive models of MCI-to-AD progression that combine magnetic resonance imaging (MRI)-based markers (cortical thickness and volume of subcortical structures) with neuropsychological tests. These models were built with longitudinal data and validated using baseline values. By using a linear mixed effects approach, we modeled the longitudinal trajectories of the markers. A set of longitudinal features potentially discriminating between MCI subjects who convert to dementia and those who remain stable over a period of 3 years was obtained. Classifier were trained using the marginal longitudinal trajectory residues from the selected features. Our best models predicted conversion with 77% accuracy at baseline (AUC = 0.855, 84% sensitivity, 70% specificity). As more visits were available, longitudinal predictive models improved their predictions with 84% accuracy (AUC = 0.912, 83% sensitivity, 84% specificity). The proposed approach was developed, trained and evaluated using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset with a total of 2491 visits from 610 subjects.
Insights
Predicting Alzheimer's disease (AD) conversion in mild cognitive impairment (MCI) is crucial. Longitudinal models combining MRI and neuropsychological data accurately predict MCI to AD progression, improving with more data points.
Area of Science:
- Neuroscience
- Medical Imaging
- Biostatistics
Background:
- Mild cognitive impairment (MCI) presents a significant risk for progression to Alzheimer's disease (AD).
- Early and accurate prediction of MCI to AD conversion is vital for timely intervention and disease management.
- Identifying predictive biomarkers from multimodal data remains a challenge.
Purpose of the Study:
- To develop and evaluate longitudinal predictive models for MCI to probable AD conversion.
- To quantify the impact of single- and multisource data on prediction accuracy.
- To identify a minimal set of highly predictive features for MCI conversion.
Main Methods:
- Combined magnetic resonance imaging (MRI) markers (cortical thickness, subcortical volumes) with neuropsychological tests.
- Utilized a linear mixed effects model to analyze longitudinal data trajectories.
- Trained classifiers on marginal longitudinal trajectory residues of selected features.
Main Results:
- Models achieved 77% accuracy (AUC=0.855) at baseline using selected longitudinal features.
- Incorporating more longitudinal data improved prediction accuracy to 84% (AUC=0.912).
- The approach was validated on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
Conclusions:
- Longitudinal predictive models integrating MRI and neuropsychological data show high accuracy in predicting MCI to AD conversion.
- The predictive performance improves with the inclusion of more longitudinal data points.
- This approach can identify key features for early AD detection in MCI patients.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment